Back

Care discrepancy in the management of the cardiorenal-metabolic syndrome: real-world analysis of SGLT2 inhibitor use in heart failure, chronic kidney disease, and type 2 diabetes

10 May 2026 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Navigating the cardio-renal syndrome (1) Comorbidities Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Miss Elisa Ziegler

Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Undiagnosed chronic kidney disease, outcomes, and finerenone in heart failure with preserved ejection fraction
Doctor J. Ostrominski (Boston, US)
Abstract Slides
Presentation thumbnail
Cardio-kidney-metabolic overlap in patients with severe heart failure: data from the HELP-HF registry
Doctor A. Villaschi (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Clinical impact of renal function deterioration while awaiting heart transplantation in patients bridged with left ventricular assist devices: a multicenter analysis of the UNOS database
Associate Professor R. Asleh (Jerusalem, IL)
Abstract Slides
Presentation thumbnail
Worsening renal function in heart failure is less harmful if associated with optimization of heart failure medication: insights from a large Registry.
Doctor D. Tomasoni (Brescia, IT)
Abstract Slides
Presentation thumbnail
Prognostic impact of cardio-renal-metabolic syndrome in HFrEF from an emerging economy
Doctor A. Perez Perez (Mexico City, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Navigating the cardio-renal syndrome (1)

The Event

Event poster

Heart Failure 2026

10 May 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Multimorbidity in heart failure: real world burden, treatment gaps, and healthcare utilization in germany
thumbnail
Congress Presentation
Chronic kidney disease in patients with heart failure in German primary care practices: the InspeCKD study
thumbnail
Congress Presentation
WATCH HF Awareness of prevalence, diagnosis and treatment of chronic heart failure in at risk patients in german primary care analysing real world data of chronic HF management in Germany

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources